"Ischemic Heart Disease" ed. by David C. Gaze
InTeOpP | 2013 | ISBN: 9535109938 9789535109938 | 210 pages | PDF | 7 MB This text reviews the epidemiology, development, risk factors, diagnosis and treatment of ischemic heart disease.
Cardiovascular disease (CVD) is ranked as the leading cause of death world wide, responsible for 17.1 million deaths globally each year. Such numbers are often difficult to comprehend. A coronary even occurs every 25 seconds and CVD kills one person every 34 seconds. 35 people under 65 years of age die prematurely every day due to CVD.
The incidence of CVD has declined in recent years due to a better understanding of the pathology, implementation of lipid lowering therapy, new drug regimens and advances in acute surgical intervention.
The disease burden has a great financial impact on global healthcare systems and major economic consequences for world economies.
Contents
Preface
1 Introduction to Ischemic Heart Disease
2 Myocardial Ischemia in Congenital Heart Disease: A Review
3 Significance of Arterial Endothelial Dysfunction and Possibilities of Its Correction in Silent Myocardial Ischemia and Diabetes Mellitus
4 Sex Differences in Sudden Cardiac Death
5 Costs of Hospitalizations with a Primary Diagnosis of Acute Myocardial Infarction Among Patients Aged 18-64 Years in the United States
6 Biomarkers of Cardiac Ischemia
7 Is Hyperuricemia a Risk Factor to Cardiovascular Disease?
8 Patient on ACS Pathway - Hypomagnesaemia a Contributory Factor to Myocardial Ischemia
9 Cell Autophagy and Myocardial Ischemia/Reperfusion Injury
10 Progenitor/Stem Cell Engineering for Treatment of Ischemic Heart Diseases: Therapeutic Potentials and Challenges
11 Role of Fatty Acid Imaging with 1231- p-methyl-p-123l-lodophenyl-Pentadecanoic Acid (1231-BMIPP) in Ischemic Heart Diseases
with TOC BookMarkLinks
0 commentaires:
Enregistrer un commentaire